Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for CDER Submissions Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 6, 2024
December 9, 2024
c7353b0c-eb15-4733-80c9-4b757e32acef
Related Documents
Providing Over-the-Counter Monograph Submissions in Electronic Format
Guidance DocumentJuly 25, 2024Center for Drug Evaluation and Research
Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry
Guidance DocumentApril 1, 2024Center for Drug Evaluation and Research
Providing Regulatory Submissions in Electronic Format --Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling: Guidance for Industry
Guidance DocumentDecember 23, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox